Patents by Inventor Andreas Gruetzkau

Andreas Gruetzkau has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 9958393
    Abstract: The invention relates to a system for acquiring discontinuous emission spectra data, whereby the data is analyzed by a multivariate statistic model or equivalent model, such as principal component analysis and the use of the system for flow cytometry.
    Type: Grant
    Filed: October 12, 2011
    Date of Patent: May 1, 2018
    Assignee: DEUTSCHES RHEUMA-FORSCHUNGSZENTRUM BERLIN
    Inventors: Toralf Kaiser, Jenny Kirsch, Andreas Gruetzkau
  • Publication number: 20130266959
    Abstract: The invention relates to a system for acquiring discontinuous emission spectra data, whereby the data is analyzed by a multivariate statistic model or equivalent model, such as principal component analysis and the use of the system for flow cytometry.
    Type: Application
    Filed: October 12, 2011
    Publication date: October 10, 2013
    Applicant: DEUTSCHES RHEUMA-FORSCHUNGSZENTRUM BERLIN
    Inventors: Toralf Kaiser, Jenny Kirsch, Andreas Gruetzkau
  • Publication number: 20110045004
    Abstract: The invention relates to a method for in-vitro detecting pathogenic T helper cells by incubating a sample of a body fluid or tissue taken from a mammal with substances specifically interacting with at least one gene product encoded by selected genes, which are differentially expressed compared to normal T helper cells, determining specific incubation products, correlating an amount of signal or change in signal with a concentration of the gene product in the sample, and detecting cell pathogenicity by comparing the concentration with another gene product concentration in a sample of non-pathogenic and/or pathogenic cells. Another object if the invention concerns a pharmaceutical composition for prophylaxis and therapy of chronicinflammatory. The invention also relates to a method for screening substances with the property to reduce the pathogenicity of T helper cells along with the symptoms of chronic inflammatory diseases.
    Type: Application
    Filed: December 22, 2008
    Publication date: February 24, 2011
    Applicant: DEUTCHES RHEUMA-FORSCHUNGSZENTRUM BERLIN
    Inventors: Andreas Radbruch, Uwe Niesner, Inka Albrecht, Hyun-Dong Chang, Torsten Stamm, Joachim Gruen, Andreas Gruetzkau